Hervé Duchesne de Lamotte

Hervé Duchesne de Lamotte is a Director of EUROBIO SCIENTIFIC. He was a member of the prior Management Board since 2010. He was General Manager of the Group since 2019 where he was in charge of M&A activities.

‍

Hervé Duchesne de Lamotte has over 35 years of international financial experience, including 30 years within the biotechnology and diagnostics industries. After having held a variety of project management positions in consultancy firms in France and the United States between 1981 and 1989, Hervé Duchesne de Lamotte took up a senior position at Paris-based asset management firms. In 1991, he moved into pharma and biotechnology as a co-founder of the IDM group, a biotechnology company where he served from 1998 as CFO for 10 years in France, Canada, and the United States. From 2006 to 2008 he was subsequently appointed General Manager France, at IDM Paris until selling the company to the Takeda pharmaceutical group in 2009. Prior to joining Eurobio Scientific, Hervé Duchesne de Lamotte managed Cirrus Finance Management, a consultancy firm specializing in business and organizational strategies. He served as Board member of IDM and France Biotech.

‍

Hervé Duchesne de Lamotte has an MBA in finance and a Master of Science from MIT. His first degree was in aeronautical engineering (SupAero).